Windtree Therapeutics, Inc. (WINT)
0.0146
0.00 (0.00%)
USD |
OTCM |
Apr 15, 15:38
Windtree Therapeutics Research and Development Expense (Annual) : 16.19M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |
| Plus Therapeutics, Inc. | 8.379M |
| Halozyme Therapeutics, Inc. | 81.49M |
| AIM ImmunoTech, Inc. | 2.786M |